Clinical Trial Update: Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit [Phase 1]

View source ↗

Summary

A completed Phase 1 trial assessing an autologous neo-urinary conduit for incontinent urinary diversion in bladder cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Tengion | Conditions: Bladder Cancer | Phase 1 | Status: COMPLETED